Hartmannuv Roztok Viaflo

Hartmannuv Roztok Viaflo is an intravenous electrolyte solution that contains potassium chloride, sodium chloride, calcium chloride dihydrate, and sodium lactate. It is supplied as a sterile solution for injection intended for fluid and electrolyte replenishment. The product is marketed in the European Union and is available by prescription. It is used to restore plasma volume and correct electrolyte imbalances in clinical settings, in hospitalized patients, and during surgery.

Hartmannuv Roztok Viaflo is indicated for several clinical situations where fluid and electrolyte balance must be rapidly restored.

- Replacement of potassium, sodium, calcium, and lactate in patients with electrolyte depletion. - Fluid resuscitation in hypovolemic states such as trauma, surgery, or severe dehydration. - Management of metabolic acidosis by providing lactate which is metabolized to bicarbonate. - Support during renal replacement therapy or dialysis when electrolyte losses are anticipated. - Use in perioperative care to maintain intravascular volume and electrolyte homeostasis.

The safety profile of Hartmannuv Roztok Viaflo reflects the expected effects of intravenous electrolyte administration.

Common: - Mild irritation at the infusion site. - Transient increase in serum potassium or sodium levels. - Slight nausea or vomiting. - Temporary feeling of warmth or flushing.

Serious: - Hyperkalemia leading to cardiac arrhythmias. - Hypernatremia causing neurological symptoms. - Severe allergic reaction such as anaphylaxis.

When prescribing Hartmannuv Roztok Viaflo, clinicians should consider several precautions to minimize risk.

- Assess baseline electrolyte concentrations and renal function before initiation. - Adjust infusion rate in patients with cardiac disease or fluid overload risk. - Use caution in neonates, infants, and the elderly due to altered fluid balance. - Monitor serum electrolytes and acid–base status during therapy. - Avoid rapid administration in patients with known hypersensitivity to any component. - Do not exceed recommended total daily electrolyte intake.

Hartmannuv Roztok Viaflo may interact with other medications that affect electrolyte levels or fluid balance.

Avoid: - Concurrent use of potassium-sparing diuretics or potassium supplements that could cause hyperkalemia. - High-dose sodium bicarbonate therapy that may exacerbate hypernatremia. - Intravenous calcium gluconate when calcium levels are already elevated.

Use with caution: - Loop diuretics, which may increase electrolyte losses and require closer monitoring. - ACE inhibitors or ARBs, as they can alter potassium handling. - Insulin therapy, which can shift potassium intracellularly.